bpc 157 clinical trials human evidence Peptide BPC-157 bpc-157 human clinical trials evidence
Description
Side effects may include gastrointestinal upset, headache, or changes in appetite
The use of 2.5 mg per mL concentrations of triamcinolone acetonide (rather than 5 mg per mL of 10 mg per mL) may reduce absorption and therefore systemic side effects as well
Mild side effects can include tenderness at the injection site, slight swelling, or redness
The functions of Atg8-family proteins in autophagy and cancer: linked or unrelated
